ATLAS / Macro Radar / Reporting / CUE

Cue Biopharma, Inc. (CUE) reporting calendar

Cue Biopharma, Inc. files periodic reports with the SEC as CUE on Nasdaq. Atlas tracks 34 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
20 Jul 2026 – 6 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
34

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CUE market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001193125-26-224091
10-K31 Dec 202516 Mar 202675 days0001193125-26-108287
10-Q30 Sep 202512 Nov 202543 days0001193125-25-277466
10-Q30 Jun 202512 Aug 202543 days0000950170-25-107270
10-Q31 Mar 202512 May 202542 days0000950170-25-069125
10-K31 Dec 202431 Mar 202590 days0000950170-25-047677
10-Q30 Sep 202414 Nov 202445 days0000950170-24-127005
10-Q30 Jun 202414 Aug 202445 days0000950170-24-096967
10-Q31 Mar 20249 May 202439 days0000950170-24-056838
10-K31 Dec 202328 Mar 202488 days0000950170-24-038059
10-Q30 Sep 20233 Nov 202334 days0000950170-23-058838
10-Q30 Jun 20238 Aug 202339 days0000950170-23-039770
10-Q31 Mar 20239 May 202339 days0000950170-23-019646
10-K31 Dec 202221 Mar 202380 days0000950170-23-008927
10-Q30 Sep 202214 Nov 202245 days0000950170-22-024991
10-Q30 Jun 20224 Aug 202235 days0000950170-22-014747
10-Q31 Mar 202210 May 202240 days0000950170-22-008990
10-K31 Dec 202116 Mar 202275 days0000950170-22-003969
10-Q30 Sep 20219 Nov 202140 days0001564590-21-055766
10-Q30 Jun 20219 Aug 202140 days0001564590-21-042619
10-Q31 Mar 202110 May 202140 days0001564590-21-026048
10-K31 Dec 20209 Mar 202168 days0001564590-21-011777
10-Q30 Sep 20209 Nov 202040 days0001564590-20-052490
10-Q30 Jun 20207 Aug 202038 days0001564590-20-038375
10-Q31 Mar 20207 May 202037 days0001564590-20-022851
10-K31 Dec 201912 Mar 202072 days0001564590-20-010212
10-Q30 Sep 20197 Nov 201938 days0001564590-19-041703
10-Q30 Jun 20198 Aug 201939 days0001564590-19-030813
10-Q31 Mar 20198 May 201938 days0001564590-19-017298
10-K31 Dec 201814 Mar 201973 days0001564590-19-007832
10-Q30 Sep 201813 Nov 201844 days0001564590-18-029316
10-Q30 Jun 201813 Aug 201844 days0001564590-18-021470
10-Q31 Mar 201814 May 201844 days0001564590-18-013461
10-K31 Dec 201729 Mar 201888 days0001144204-18-017978

Source: SEC EDGAR company submissions for CIK 0001645460. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.